The role of estrogens in epigenetic regulation of hypoxia-related gene expression in non-small cell lung cancer development

2013/11/B/NZ5/00039

Keywords

Descriptors

  • NZ5_3: Patogeneza chorób człowieka
  • NZ1_1: Biologia molekularna
  • NZ3_1: Biologia komórki

Panel

NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)

Host institution

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Medyczny

Voivodeship: wielkopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

prof. Paweł Piotr Jagodziński

Number of co-investigators in the project: 10

Call

OPUS 6 – announced on 2013-09-16

Amount awarded
931 627 PLN
Project start date
2014-07-22
Project end date
2020-01-21
Project duration
66 months (the same as in the proposal)
Project status
Project settled

Equipment purchased [PL]

  1. Inkubator CO2 z płaszczem wodnym Forma* Series II 3110. Cost: 70 000 PLN

Information in the final report

Publication in academic press/journals (4)

  1. Increased expression of 17-beta-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer

    Authors:
    Drzewiecka H, Gałęcki B, Jarmołowska-Jurczyszyn D, Kluk A, Dyszkiewicz W, Jagodziński PP
    Academic press:
    Lung Cancer (year: 2015, volume: 87, pages: 107-116), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.lungcan.2014.12.012 – link to the publication
  2. Increased expression of proline-, glutamic acid- and leucine-rich protein PELP1 in non-small cell lung cancer

    Authors:
    Słowikowski BK, Gałęcki B, Dyszkiewicz W, Jagodziński PP
    Academic press:
    Biomedicine & Pharmacotherapy (year: 2015, volume: 73, pages: 97-101), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.biopha.2015.05.015 – link to the publication
  3. Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers

    Authors:
    Hanna Drzewiecka, Bartłomiej Gałęcki, Donata Jarmołowska-Jurczyszyn, Andrzej Kluk, Wojciech Dyszkiewicz, Paweł P. Jagodziński
    Academic press:
    Journal of Cancer Research and Clinical Oncology (year: 2016, volume: 142, pages: 1927-1946), Publisher: Springer
    Status:
    Published
    DOI:
    10.1007/s00432-016-2195-3 – link to the publication
  4. Altered expression of 17-beta-hydroxysteroid dehydrogenase type 2 and its prognostic significance in non-small cell lung cancer

    Authors:
    Hanna Drzewiecka, Donata Jarmołowska-Jurczyszyn, Andrzej Kluk, Bartłomiej Gałęcki, Wojciech Dyszkiewicz, Paweł P. Jagodziński
    Academic press:
    International Journal of Oncology (year: 2020, volume: 56, pages: 1352-1372), Publisher: Spandidos Publications
    Status:
    Published
    DOI:
    10.3892/ijo.2020.5014 – link to the publication

Articles in post-conference publications (1)

  1. Expression of 17-beta-hydroxysteroid dehydrogenase type 1 and type 2 in non-small cell lung cancer

    Authors:
    Hanna Drzewiecka, Bartłomiej Gałęcki, Wojciech Dyszkiewicz, Paweł P. Jagodziński.
    Conference:
    26th Bilateral Symposium Poznan-Halle From Molecular Medicine to Public Health - Translational Research in Cardiovascular Medicine and Oncology (year: 2015, pages: 21), Publisher: MARTIN LUTHER UNIVERSITY HALLE−WITTENBERG
    Date:
    conference 23-25 październik
    Status:
    Published

« New search

Graphic design and implementation: Jakub Piotrowski